Extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALTomas) originate from mucosa-associated lymphoid tissue (MALT) and present as low-grade, localized lymphomas, forming 8% of all non-Hodgkin lymphomas (NHLs).
Introduction
Synchronous presentation of two extranodal lymphomas: follicular lymphoma and extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALToma)
Just before the diagnosis of the second lymphoma and after the wedge biopsy, the patient was given two cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) because of the progressive clinical symptoms, in addition to antibiotherapy for Helicobacter pylori. After the diagnosis of FL, the Follicular Lymphoma International Prognostic Index (FLIPI) prognostic index score was calculated as "3: high risk", and rituximab was added to the treatment protocol. After four cycles of CHOP plus the monoclonal antibody rituximab (R-CHOP), the patient achieved complete response with no pathological 18-FDG involvement on PET/CT and continued with rituximab maintenance therapy. The patient was disease free after 1-year follow-up with complete response.
Discussion
The frequency of occurrence of synchronous multiple malignancies is very low among the population. After the treatment of primary solid tumors, hematological secondary malignancies due to chemo/ radiotherapy can be seen [3] . The most commonly reported double malignancies are solid tumors with hematological neoplasms, such as gastric cancer with diffuse large B-cell lymphoma (DLBCL), lung adenocarcinoma with chronic myeloid leukemia, colon cancer with myeloma, and lung cancer with myeloma [3] . However, synchronous presentation of two hematologic neoplasms is extremely rare and reported generally as myeloproliferative diseases (MPDs) with lymphoproliferative diseases [3] , and the combinations were as follows: concomitant histiocytic sarcoma and DLBCL [4] , DLBCL with myeloma [5] , mantle cell lymphoma with chronic lymphocytic leukemia (CLL) [6, 7] , and DLBCL with Hodgkin's lymphoma [8, 9] , MPDs with CLL, and MPDs with hairy cell leukemia [10] .
MALToma originates from the MALT tissue, which is widely localized throughout the whole body, such as in the gastrointestinal tract, salivary glands, lungs, and so on. The most common organ of localization is the stomach, with an incidence of 50% of the gastrointestinal MALTomas [11] . The diagnosis generally depends on the exclusion of other types of low-grade lymphomas with the presence of 
